Multiple myeloma trials in Georgia
1 trial · From ClinicalTrials.gov, checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 1RecruitingTrial-stage medicine
A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
- Where
- Tbilisi
- Age
- 18 years and over
- People
- 258 worldwide
- Run by
- Shanghai Henlius Biotech
See details and how to joinNCT07477587Registry updated 2026-09-24
All Multiple myeloma trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.